308 related articles for article (PubMed ID: 8501155)
21. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Van Herle AJ; Juppner H; Salusky IB
J Clin Endocrinol Metab; 1998 Aug; 83(8):2765-72. PubMed ID: 9709944
[TBL] [Abstract][Full Text] [Related]
22. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
[TBL] [Abstract][Full Text] [Related]
23. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
25. The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure.
Cardinal H; Brossard JH; Roy L; Lepage R; Rousseau L; D'Amour P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3839-44. PubMed ID: 9814455
[TBL] [Abstract][Full Text] [Related]
26. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
[TBL] [Abstract][Full Text] [Related]
27. Effect of rate of calcium reduction and a hypocalcemic clamp on parathyroid hormone secretion: a study in dogs.
Estepa JC; Aguilera-Tejero E; Almaden Y; Rodriguez M; Felsenfeld AJ
Kidney Int; 1999 May; 55(5):1724-33. PubMed ID: 10231434
[TBL] [Abstract][Full Text] [Related]
28. The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
Hardy-Yverneau P; Shenouda M; Moriniere P; Legallais C; Brazier M; Achard J; Fournier A
Clin Nephrol; 1998 Oct; 50(4):236-46. PubMed ID: 9799069
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
Santamaria R; Almaden Y; Felsenfeld A; Martin-Malo A; Gao P; Cantor T; Aljama P; Rodriguez M
Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822
[TBL] [Abstract][Full Text] [Related]
30. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium.
Schmitt CP; Schaefer F; Bruch A; Veldhuis JD; Schmidt-Gayk H; Stein G; Ritz E; Mehls O
J Clin Endocrinol Metab; 1996 Dec; 81(12):4236-43. PubMed ID: 8954021
[TBL] [Abstract][Full Text] [Related]
31. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Rodriguez AP; Felsenfeld AJ
J Bone Miner Res; 1997 Mar; 12(3):347-55. PubMed ID: 9076577
[TBL] [Abstract][Full Text] [Related]
32. Lack of FGF23 response to acute changes in serum calcium and PTH in humans.
Wesseling-Perry K; Wang H; Elashoff R; Gales B; Jüppner H; Salusky IB
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1951-6. PubMed ID: 25062462
[TBL] [Abstract][Full Text] [Related]
33. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.
D'Amour P; Palardy J; Bahsali G; Mallette LE; DeLéan A; Lepage R
J Clin Endocrinol Metab; 1992 Mar; 74(3):525-32. PubMed ID: 1740486
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid gland function in secondary hyperparathyroidism.
Salusky IB; Goodman WG
Pediatr Nephrol; 1996 Jun; 10(3):359-63. PubMed ID: 8792406
[TBL] [Abstract][Full Text] [Related]
35. Calcium-mediated parathyroid hormone suppression to assess progression of secondary hyperparathyroidism during treatment among incident dialysis patients.
Rodriguez M; Ureña-Torres P; Pétavy F; Cooper K; Farouk M; Goodman WG
J Clin Endocrinol Metab; 2013 Feb; 98(2):618-25. PubMed ID: 23365129
[TBL] [Abstract][Full Text] [Related]
36. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
Sørensen HA; Schwarz P; Hyldstrup L; Transbøl I
Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
[TBL] [Abstract][Full Text] [Related]
37. Effects of parathyroid hormone infusion and primary hyperparathyroidism on serum prolactin in man.
Castro JH; Caro JF; Kim HJ; Glennon JA
J Clin Endocrinol Metab; 1980 Aug; 51(2):397-8. PubMed ID: 7400304
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.
Malberti F; Surian M; Cosci P
Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the calcium-PTH axis and renal handling of phosphate by calcium and citrate clamp techniques in normal subjects and in patients with heavy proteinuria.
Saha H; Seppälä E; Mörsky P; Mustonen J; Pasternack A
Clin Nephrol; 1997 Dec; 48(6):364-70. PubMed ID: 9438095
[TBL] [Abstract][Full Text] [Related]
40. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
